Background: Varicose veins are a chronic vascular disorder influenced by factors such as inflammation, fibrosis, endothelial dysfunction, and vascular cell activation. This study evaluates the association between ten molecular biomarkers and these risk factors in patients with lower extremity varicosity to enhance understanding of the condition's pathophysiology and highlight potential diagnostic biomarkers.
Methods: A cross-sectional study was conducted involving 126 patients diagnosed with lower extremity varicosity, confirmed by duplex ultrasound, and 108 age- and sex-matched control subjects. Serum levels of ten biomarkers C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and tissue inhibitor of metalloproteinases-1, transforming growth factor-beta 1, procollagen type I N-terminal propeptide, vascular endothelial growth factor, malondialdehyde, endothelin-1, and matrix metalloproteinase-9 were quantified using ELISA. ROC curve analyses assessed the predictive value of these biomarkers.
Results: Patients with varicosity displayed significantly elevated levels of all biomarkers compared to controls, with strong associations to varicosity risk (p < 0.0001). ROC curve analysis revealed high predictive values, with AUCs ranging from 0.858 to 0.939.
Conclusion: The elevated biomarker levels suggest mechanisms including inflammation, fibrosis, endothelial dysfunction, and venous pressure in varicosity. Biomarker monitoring may support early diagnosis and management of varicose veins, enhancing patient outcomes. Future longitudinal studies are advised to further validate these associations.
{"title":"Molecular signatures of varicosity: Diagnostic insights from ten biomarkers.","authors":"Apurba Ganguly, Sudip Kumar Banerjee, Vidya Sagar Gubby Venkatesh, Dinesh Kumar Singal, Anondeep Ganguly","doi":"10.22088/cjim.16.4.700","DOIUrl":"10.22088/cjim.16.4.700","url":null,"abstract":"<p><strong>Background: </strong>Varicose veins are a chronic vascular disorder influenced by factors such as inflammation, fibrosis, endothelial dysfunction, and vascular cell activation. This study evaluates the association between ten molecular biomarkers and these risk factors in patients with lower extremity varicosity to enhance understanding of the condition's pathophysiology and highlight potential diagnostic biomarkers.</p><p><strong>Methods: </strong>A cross-sectional study was conducted involving 126 patients diagnosed with lower extremity varicosity, confirmed by duplex ultrasound, and 108 age- and sex-matched control subjects. Serum levels of ten biomarkers C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and tissue inhibitor of metalloproteinases-1, transforming growth factor-beta 1, procollagen type I N-terminal propeptide, vascular endothelial growth factor, malondialdehyde, endothelin-1, and matrix metalloproteinase-9 were quantified using ELISA. ROC curve analyses assessed the predictive value of these biomarkers.</p><p><strong>Results: </strong>Patients with varicosity displayed significantly elevated levels of all biomarkers compared to controls, with strong associations to varicosity risk (p < 0.0001). ROC curve analysis revealed high predictive values, with AUCs ranging from 0.858 to 0.939.</p><p><strong>Conclusion: </strong>The elevated biomarker levels suggest mechanisms including inflammation, fibrosis, endothelial dysfunction, and venous pressure in varicosity. Biomarker monitoring may support early diagnosis and management of varicose veins, enhancing patient outcomes. Future longitudinal studies are advised to further validate these associations.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"16 4","pages":"700-711"},"PeriodicalIF":1.0,"publicationDate":"2025-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12694810/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145740775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-18eCollection Date: 2025-01-01DOI: 10.22088/cjim.16.4.755
Haneen Ali Kareem, Haydar Hassan Ghadi
Background: CML, a blood cancer characterized by excessive myeloid cell proliferation, stems from the BCR-ABL1 gene fusion. This research aimed to uncover why leukemic stem cells resist treatment and explore innovative immune-based therapies to improve patient outcomes.
Methods: This study investigated the immunologic phenotypes (CD8, CD27, CD197, and CD45RA) of T cell subsets (TN, TCM, TEM, and TEF) in the peripheral blood of chronic myeloid leukemia patients in the chronic phase who achieved a complete molecular response to tyrosine kinase inhibitors. The treatment-free remission (TFR) patients were compared to age- and gender-matched healthy volunteers using multicolor flow cytometry for analysis.
Results: Flow cytometry analysis unveiled notable shifts in CD8+ T cell subsets. CML-CP patients showed a marked decrease in central memory T cells (TCM), dropping to 7.2% of the CD8+ population. Conversely, these patients exhibited substantial increases in effector memory T (TEM) and effector T (TEF) cells, rising to 37.6% and 24.4% respectively. The most statistically significant change occurred in the CD8+ TEF subset. CML-CP patients displayed a 24.4% presence of these cells, compared to only 15.7% in control groups. These findings suggest a distinct immunological profile in CML-CP, potentially impacting disease progression and treatment strategies.
Conclusion: Tyrosine kinase inhibitors restore the distribution of memory T cells in patients with chronic myeloid leukemia (CML), but T cell exhaustion remains an issue. This situation highlights the need for alternative activation strategies to enhance immunity.
{"title":"Reshape memory T cell landscape in CML patients' blood by tyrosine kinase inhibitors.","authors":"Haneen Ali Kareem, Haydar Hassan Ghadi","doi":"10.22088/cjim.16.4.755","DOIUrl":"10.22088/cjim.16.4.755","url":null,"abstract":"<p><strong>Background: </strong>CML, a blood cancer characterized by excessive myeloid cell proliferation, stems from the BCR-ABL1 gene fusion. This research aimed to uncover why leukemic stem cells resist treatment and explore innovative immune-based therapies to improve patient outcomes.</p><p><strong>Methods: </strong>This study investigated the immunologic phenotypes (CD8, CD27, CD197, and CD45RA) of T cell subsets (TN, TCM, TEM, and TEF) in the peripheral blood of chronic myeloid leukemia patients in the chronic phase who achieved a complete molecular response to tyrosine kinase inhibitors. The treatment-free remission (TFR) patients were compared to age- and gender-matched healthy volunteers using multicolor flow cytometry for analysis.</p><p><strong>Results: </strong>Flow cytometry analysis unveiled notable shifts in CD8+ T cell subsets. CML-CP patients showed a marked decrease in central memory T cells (TCM), dropping to 7.2% of the CD8+ population. Conversely, these patients exhibited substantial increases in effector memory T (TEM) and effector T (TEF) cells, rising to 37.6% and 24.4% respectively. The most statistically significant change occurred in the CD8+ TEF subset. CML-CP patients displayed a 24.4% presence of these cells, compared to only 15.7% in control groups. These findings suggest a distinct immunological profile in CML-CP, potentially impacting disease progression and treatment strategies.</p><p><strong>Conclusion: </strong>Tyrosine kinase inhibitors restore the distribution of memory T cells in patients with chronic myeloid leukemia (CML), but T cell exhaustion remains an issue. This situation highlights the need for alternative activation strategies to enhance immunity.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"16 4","pages":"755-766"},"PeriodicalIF":1.0,"publicationDate":"2025-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12695480/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145754988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-18eCollection Date: 2025-01-01DOI: 10.22088/cjim.16.4.741
Parsa Aghajani, Seyed Reza Hosseini, Ali Bijani, Reza Ghadimi
Background: Kidney stones are a condition that is prevalent in the geriatric group and significantly impairs their quality of life. The formation of stones may be associated with insulin resistance, which can be measured using the triglyceride-glucose (TyG) index.
Methods: This cross-sectional study was part of the second phase of the Amirkola Health and Ageing Project (AHAP) Cohort, which was initiated in 2011 with a focus on individuals aged 60 years and older. The study population included a case group comprising 349 individuals diagnosed with kidney stones and a control group of 349 individuals without kidney stones, matched by age and sex. The data have been analyzed afterwards.
Results: The mean TyG index was 4.77±0.33 in individuals with kidney stones and 4.75±0.34 in the group without kidney stones. The observed difference did not achieve statistical significance. Moreover, after logistic regression analyses, both crude and adjusted logistic regression analyses indicated no statistically significant relationship between the TyG index and the presence of kidney stones in the studied population.
Conclusion: The findings of this study indicate that there is no significant link between the TyG index and the occurrence of kidney stones among older adults.
{"title":"Association between triglyceride-glucose index and nephrolithiasis among the elderly in Amirkola: A cross-sectional population-based study.","authors":"Parsa Aghajani, Seyed Reza Hosseini, Ali Bijani, Reza Ghadimi","doi":"10.22088/cjim.16.4.741","DOIUrl":"10.22088/cjim.16.4.741","url":null,"abstract":"<p><strong>Background: </strong>Kidney stones are a condition that is prevalent in the geriatric group and significantly impairs their quality of life. The formation of stones may be associated with insulin resistance, which can be measured using the triglyceride-glucose (TyG) index.</p><p><strong>Methods: </strong>This cross-sectional study was part of the second phase of the Amirkola Health and Ageing Project (AHAP) Cohort, which was initiated in 2011 with a focus on individuals aged 60 years and older. The study population included a case group comprising 349 individuals diagnosed with kidney stones and a control group of 349 individuals without kidney stones, matched by age and sex. The data have been analyzed afterwards.</p><p><strong>Results: </strong>The mean TyG index was 4.77±0.33 in individuals with kidney stones and 4.75±0.34 in the group without kidney stones. The observed difference did not achieve statistical significance. Moreover, after logistic regression analyses, both crude and adjusted logistic regression analyses indicated no statistically significant relationship between the TyG index and the presence of kidney stones in the studied population.</p><p><strong>Conclusion: </strong>The findings of this study indicate that there is no significant link between the TyG index and the occurrence of kidney stones among older adults.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"16 4","pages":"741-746"},"PeriodicalIF":1.0,"publicationDate":"2025-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12694865/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145741311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Thyroid nodules are a significant clinical concern due to their potential for malignancy. Research suggests prolactin, a known mitogen, may contribute to cancer development, and elevated thyroid peroxidase antibody (TPO-Ab) levels are linked to increased thyroid nodularity in hyperprolactinemia. This study investigates the relationship between serum prolactin levels, thyroid nodularity, and TPO-Ab presence.
Methods: Ninety patients were divided into three groups of 30: a control group without nodules, and two case groups with nodules (one TPO-Ab positive, one TPO-Ab negative). Serum prolactin, TPO-Ab, thyroid stimulating hormone, T4, and thyroid ultrasound data were analyzed. Statistical significance was set at p < 0.05.
Results: The mean age of the participants was 46.07±12.40 years, with 16 (17.8%) males and 74 (82.2%) females. Serum TSH, prolactin, and TPO-Ab levels were significantly higher in the case group than in the control group (P=0.041, 0.050, and 0.000, respectively). The case group had more instances of hyperprolactinemia than the control group (35% vs. 13.3%) (OR = 3.5, CI 95% = 1.08-11.38, P=0.031). Furthermore, the TPO-Ab positive group demonstrated greater solidity than the TPO-Ab negative group (93.3% vs 73.3%, P=0.038).
Conclusion: Our study revealed a positive correlation between thyroid nodules and increased serum TSH, prolactin, and TPO-Ab levels. Furthermore, we discovered that TPO-Ab positive nodules exhibit greater solidity and elevated TSH levels.
背景:甲状腺结节是一个重要的临床关注,由于其潜在的恶性肿瘤。研究表明,催乳素,一种已知的有丝分裂原,可能有助于癌症的发展,甲状腺过氧化物酶抗体(TPO-Ab)水平升高与高催乳素血症中甲状腺结节性增加有关。本研究探讨血清催乳素水平、甲状腺结节和TPO-Ab存在之间的关系。方法:90例患者分为3组,每组30例:无结节的对照组和有结节的2例组(TPO-Ab阳性1例,TPO-Ab阴性1例)。分析血清催乳素、TPO-Ab、促甲状腺激素、T4及甲状腺超声数据。p < 0.05为差异有统计学意义。结果:参与者平均年龄46.07±12.40岁,男性16人(17.8%),女性74人(82.2%)。病例组血清TSH、催乳素和TPO-Ab水平显著高于对照组(P值分别为0.041、0.050和0.000)。病例组高泌乳素血症发生率高于对照组(35% vs. 13.3%) (OR = 3.5, CI 95% = 1.08-11.38, P=0.031)。此外,TPO-Ab阳性组比TPO-Ab阴性组表现出更大的固形性(93.3% vs 73.3%, P=0.038)。结论:我们的研究显示甲状腺结节与血清TSH、催乳素和TPO-Ab水平升高呈正相关。此外,我们发现TPO-Ab阳性结节表现出更大的坚固性和更高的TSH水平。
{"title":"Relationship between thyroid nodule, prolactin, and thyroid peroxidase antibody levels: A case-control study.","authors":"Maedeh Mataji, Mehran Frouzanian, Zahra Kashi, Amirsaleh Abdollahi, Adele Bahar, Reza Ali Mohammadpour","doi":"10.22088/cjim.16.4.712","DOIUrl":"10.22088/cjim.16.4.712","url":null,"abstract":"<p><strong>Background: </strong>Thyroid nodules are a significant clinical concern due to their potential for malignancy. Research suggests prolactin, a known mitogen, may contribute to cancer development, and elevated thyroid peroxidase antibody (TPO-Ab) levels are linked to increased thyroid nodularity in hyperprolactinemia. This study investigates the relationship between serum prolactin levels, thyroid nodularity, and TPO-Ab presence.</p><p><strong>Methods: </strong>Ninety patients were divided into three groups of 30: a control group without nodules, and two case groups with nodules (one TPO-Ab positive, one TPO-Ab negative). Serum prolactin, TPO-Ab, thyroid stimulating hormone, T4, and thyroid ultrasound data were analyzed. Statistical significance was set at p < 0.05.</p><p><strong>Results: </strong>The mean age of the participants was 46.07±12.40 years, with 16 (17.8%) males and 74 (82.2%) females. Serum TSH, prolactin, and TPO-Ab levels were significantly higher in the case group than in the control group (P=0.041, 0.050, and 0.000, respectively). The case group had more instances of hyperprolactinemia than the control group (35% vs. 13.3%) (OR = 3.5, CI 95% = 1.08-11.38, P=0.031). Furthermore, the TPO-Ab positive group demonstrated greater solidity than the TPO-Ab negative group (93.3% vs 73.3%, P=0.038).</p><p><strong>Conclusion: </strong>Our study revealed a positive correlation between thyroid nodules and increased serum TSH, prolactin, and TPO-Ab levels. Furthermore, we discovered that TPO-Ab positive nodules exhibit greater solidity and elevated TSH levels.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"16 4","pages":"712-717"},"PeriodicalIF":1.0,"publicationDate":"2025-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12694812/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145741176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-18eCollection Date: 2025-01-01DOI: 10.22088/cjim.16.4.718
Amir Gholami, Seyyed Ali Hosseini, Hemmat Gholinia, Seyyed Hossein Mousavie Anijdan
Background: Differentiated thyroid carcinoma (DTC) comprises nearly 90% of all thyroid malignancies. The main focus of our study was to examine how measuring Tg at multiple time points could predict the persistence and/or recurrence of both local and distant diseases.
Methods: In this retrospective, single-center, observational study, we examined records of all patients who underwent total thyroidectomy for DTC and received radioactive iodine (RAI) ablation/therapy at the Nuclear Medicine of Shahid Beheshti Hospital. Blood samples were collected at two time, approximately 30 days before RAI (Tg-30 and TSH-30) and the same day of RAI, after TSH-stimulation (Tg-0 and TSH-0). During the follow-up period, patients were categorized into the four groups according to the ATA guideline. Group with an excellent response (ER), nodal disease (ND), distant disease (DD) and partial response (PR).
Results: A significant difference between Tg-0 and Tg-30 was observed only in the ER group and the other 3 groups (p<0.001), and no significant difference was observed between the remaining 3 groups (p>0.05). Cut-off point of 1.35 ng/mL for the Tg-30 and 4.7 ng/mL for the Tg-0 was used with best sensitivity and specificity for differentiation of ER vs. ND. A cut-off point of 14.25 ng/mL for the Tg-30 and 40 ng/mL for the Tg-0 was able to correctly identify ER vs. DD.
Conclusion: By using the cut-off values obtained in this study, it is possible to more accurately predict local or distant recurrences. Maybe these patients need a shorter follow-up period that leads to more appropriate treatment decisions.
{"title":"Predictive value of serum thyroglobulin after surgery and prior to I-131 therapy in patients with differentiated thyroid carcinoma, examined at two different time intervals.","authors":"Amir Gholami, Seyyed Ali Hosseini, Hemmat Gholinia, Seyyed Hossein Mousavie Anijdan","doi":"10.22088/cjim.16.4.718","DOIUrl":"10.22088/cjim.16.4.718","url":null,"abstract":"<p><strong>Background: </strong>Differentiated thyroid carcinoma (DTC) comprises nearly 90% of all thyroid malignancies. The main focus of our study was to examine how measuring Tg at multiple time points could predict the persistence and/or recurrence of both local and distant diseases.</p><p><strong>Methods: </strong>In this retrospective, single-center, observational study, we examined records of all patients who underwent total thyroidectomy for DTC and received radioactive iodine (RAI) ablation/therapy at the Nuclear Medicine of Shahid Beheshti Hospital. Blood samples were collected at two time, approximately 30 days before RAI (Tg-30 and TSH-30) and the same day of RAI, after TSH-stimulation (Tg-0 and TSH-0). During the follow-up period, patients were categorized into the four groups according to the ATA guideline. Group with an excellent response (ER), nodal disease (ND), distant disease (DD) and partial response (PR).</p><p><strong>Results: </strong>A significant difference between Tg-0 and Tg-30 was observed only in the ER group and the other 3 groups (p<0.001), and no significant difference was observed between the remaining 3 groups (p>0.05). Cut-off point of 1.35 ng/mL for the Tg-30 and 4.7 ng/mL for the Tg-0 was used with best sensitivity and specificity for differentiation of ER vs. ND. A cut-off point of 14.25 ng/mL for the Tg-30 and 40 ng/mL for the Tg-0 was able to correctly identify ER vs. DD.</p><p><strong>Conclusion: </strong>By using the cut-off values obtained in this study, it is possible to more accurately predict local or distant recurrences. Maybe these patients need a shorter follow-up period that leads to more appropriate treatment decisions.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"16 4","pages":"718-724"},"PeriodicalIF":1.0,"publicationDate":"2025-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12694882/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145741234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-18eCollection Date: 2025-01-01DOI: 10.22088/cjim.16.4.747
Maryam Haghighi-Morad, Reza Rezaei, Muhanna Kazempour, Mohammad Mehdi Emam, Arezoo Ranjbar Arani, Mahbobeh Taheri, Parisa Delkash
Background: Takayasu arteritis (TAK) is a rare large-vessel vasculitis that affects the carotid arteries. Increased intima-media thickness (IMT) and atherosclerotic changes are detectable by ultrasonography (US). This study aimed to evaluate detailed carotid sonographic features in TAK and compare them with diabetes mellitus (DM), as well as to assess correlations between sonographic parameters and inflammatory markers.
Methods: In this case-control study, 15 patients with TAK fulfilling the 1990 American College of Rheumatology criteria (2012-2022) and 15 patients with DM were evaluated at Loghman Hakim Hospital. Cardiovascular risk factors, carotid ultrasonography, and serum inflammatory markers were assessed. Data were analyzed using univariate and multiple regression tests (SPSS V24).
Results: Atherosclerotic plaques were found in 46.7% of TAK and 53.3% of DM patients. IMT of common (CCA) and internal carotid arteries (ICA) was significantly higher in TAK (p<0.05). The macaroni sign (P=0.001), turbulent flow (P=0.006), and higher CCA resistivity index (RI) (P=0.047) were characteristic of TAK. ESR and CRP correlated with pre-bifurcation CCA mean IMT (p<0.05). Each unit increase in CRP was associated with a 0.02 mm increase in right CCA IMT (P=0.05).
Conclusion: Carotid ultrasonography is a valuable tool in evaluating TAK. Distinguishing features include the presence of the macaroni sign, turbulent flow, and higher IMT and RI. Increased IMT was associated with elevated CRP.
{"title":"Carotid sonographic features in Takayasu's arteritis: A case-control study.","authors":"Maryam Haghighi-Morad, Reza Rezaei, Muhanna Kazempour, Mohammad Mehdi Emam, Arezoo Ranjbar Arani, Mahbobeh Taheri, Parisa Delkash","doi":"10.22088/cjim.16.4.747","DOIUrl":"10.22088/cjim.16.4.747","url":null,"abstract":"<p><strong>Background: </strong>Takayasu arteritis (TAK) is a rare large-vessel vasculitis that affects the carotid arteries. Increased intima-media thickness (IMT) and atherosclerotic changes are detectable by ultrasonography (US). This study aimed to evaluate detailed carotid sonographic features in TAK and compare them with diabetes mellitus (DM), as well as to assess correlations between sonographic parameters and inflammatory markers.</p><p><strong>Methods: </strong>In this case-control study, 15 patients with TAK fulfilling the 1990 American College of Rheumatology criteria (2012-2022) and 15 patients with DM were evaluated at Loghman Hakim Hospital. Cardiovascular risk factors, carotid ultrasonography, and serum inflammatory markers were assessed. Data were analyzed using univariate and multiple regression tests (SPSS V24).</p><p><strong>Results: </strong>Atherosclerotic plaques were found in 46.7% of TAK and 53.3% of DM patients. IMT of common (CCA) and internal carotid arteries (ICA) was significantly higher in TAK (p<0.05). The macaroni sign (P=0.001), turbulent flow (P=0.006), and higher CCA resistivity index (RI) (P=0.047) were characteristic of TAK. ESR and CRP correlated with pre-bifurcation CCA mean IMT (p<0.05). Each unit increase in CRP was associated with a 0.02 mm increase in right CCA IMT (P=0.05).</p><p><strong>Conclusion: </strong>Carotid ultrasonography is a valuable tool in evaluating TAK. Distinguishing features include the presence of the macaroni sign, turbulent flow, and higher IMT and RI. Increased IMT was associated with elevated CRP.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"16 4","pages":"747-757"},"PeriodicalIF":1.0,"publicationDate":"2025-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12694889/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145741318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Cardiovascular diseases (CVDs) are a significant cause of morbidity and mortality worldwide, particularly among the Iranian population. Assessing left ventricular (LV) dimensions and interventricular septum (IVS) thickness is crucial in diagnosing and managing various cardiac conditions. This study aimed to compare LV dimensions and IVS thickness using electrocardiogram (ECG) gated computed tomography angiography (CTA) and echocardiography.
Methods: A cross-sectional study was conducted on 160 Iranian individuals without known CVD from March to September 2023 in Hospital, Tabriz, Iran. Participants underwent both ECG-gated CTA and echocardiography for assessment of LV dimensions and IVS thickness. Measurements were performed by experienced radiologists and cardiologists, respectively. Echocardiography and CTA were analyzed for their correlation using Pearson's correlation coefficient. Statistical analysis was conducted using SPSS V25 software.
Results: The study revealed a significant correlation between various LV dimensions and wall thickness measurements obtained from echocardiography and CTA (p<0.000). Strong and significant correlations were found in measurements taken from different views and regions of the heart, including the parasternal long-axis (PLAX) view, Mid and Base views, and the anteroseptal and inferoseptal regions (p<0.000). Echocardiography measurements also showed significant correlations, with varying strengths.
Conclusion: The comparative analysis of LV dimensions and IVS thickness using ECG-gated CTA and echocardiography demonstrated significant correlations, suggesting the potential clinical utility of both imaging techniques in diagnosing and managing CVD in the Iranian population. The 4-chamber and PSAX methods can be used interchangeably to measure interventricular septum thickness. Further research is required to validate and expand upon these results.
{"title":"Exploring left ventricle dimensions and interventricular septum thickness in the Iranian population: A comparative analysis through ECG gated, CT angiography and echocardiography.","authors":"Naser Khezerlouy-Aghdam, Shahla Meshgi, Zahra Hosnavi, Haleh Bodagh, Mohammadreza Motazedian, Razieh Parizad, Asma Yousefzadeh","doi":"10.22088/cjim.16.4.692","DOIUrl":"10.22088/cjim.16.4.692","url":null,"abstract":"<p><strong>Background: </strong>Cardiovascular diseases (CVDs) are a significant cause of morbidity and mortality worldwide, particularly among the Iranian population. Assessing left ventricular (LV) dimensions and interventricular septum (IVS) thickness is crucial in diagnosing and managing various cardiac conditions. This study aimed to compare LV dimensions and IVS thickness using electrocardiogram (ECG) gated computed tomography angiography (CTA) and echocardiography.</p><p><strong>Methods: </strong>A cross-sectional study was conducted on 160 Iranian individuals without known CVD from March to September 2023 in Hospital, Tabriz, Iran. Participants underwent both ECG-gated CTA and echocardiography for assessment of LV dimensions and IVS thickness. Measurements were performed by experienced radiologists and cardiologists, respectively. Echocardiography and CTA were analyzed for their correlation using Pearson's correlation coefficient. Statistical analysis was conducted using SPSS V25 software.</p><p><strong>Results: </strong>The study revealed a significant correlation between various LV dimensions and wall thickness measurements obtained from echocardiography and CTA (p<0.000). Strong and significant correlations were found in measurements taken from different views and regions of the heart, including the parasternal long-axis (PLAX) view, Mid and Base views, and the anteroseptal and inferoseptal regions (p<0.000). Echocardiography measurements also showed significant correlations, with varying strengths.</p><p><strong>Conclusion: </strong>The comparative analysis of LV dimensions and IVS thickness using ECG-gated CTA and echocardiography demonstrated significant correlations, suggesting the potential clinical utility of both imaging techniques in diagnosing and managing CVD in the Iranian population. The 4-chamber and PSAX methods can be used interchangeably to measure interventricular septum thickness. Further research is required to validate and expand upon these results.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"16 4","pages":"692-699"},"PeriodicalIF":1.0,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12694768/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145740816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Type 1 diabetes mellitus (T1DM) and celiac disease (CD) are autoimmune disorders with a common genetic basis. Celiac disease often presents asymptomatically, leading to delayed diagnosis and potential complications like anemia and growth delays. This research investigates the prevalence of celiac disease in T1DM patients at the Yazd Diabetes Center in 2022.
Methods: This cross-sectional study, uniquely designed and executed, involved 318 T1DM patients sampled via census. Levels of IgA anti-tissue transglutaminase (TTG) antibodies and serum IgA were measured, with individuals having TTG-IgA levels over 10 U/mL undergoing endoscopy and duodenal biopsy. The data were meticulously analyzed using SPSS V.22, with significance at a p-value < 0.05.
Results: Among the 318 patients, 25 (7.86%), comprising 15 (60%) females and 10(40%) males, underwent endoscopy and biopsy due to elevated TTG-IgA levels. Histopathological analysis revealed four (16%) patients with normal findings: 2 (8%) with Marsh type 1, 1 (4%) with Marsh type 2, and 18 (72%) with Marsh type 3. Patients with TTG levels exceeding 100 were all classified as Marsh type 3. Gender-wise, there was no significant difference in celiac disease type distribution. (P- value= 0.58).
Conclusion: This study's findings, which reveal a celiac disease prevalence in T1DM patients similar to global rates, have significant implications for clinical practice. The importance of routine celiac disease screening for these patients is underscored, as is the urgent need for extensive multi-center studies to deepen our understanding of this relationship and improve patient care.
{"title":"Association of celiac disease with type 1 diabetes: A cross-sectional analysis in 2022.","authors":"Mahtab Ordooei, Roohollah Edalatkhah, Nasim Namiranian, Zahra Khosravizade","doi":"10.22088/cjim.16.4.797","DOIUrl":"10.22088/cjim.16.4.797","url":null,"abstract":"<p><strong>Background: </strong>Type 1 diabetes mellitus (T1DM) and celiac disease (CD) are autoimmune disorders with a common genetic basis. Celiac disease often presents asymptomatically, leading to delayed diagnosis and potential complications like anemia and growth delays. This research investigates the prevalence of celiac disease in T1DM patients at the Yazd Diabetes Center in 2022.</p><p><strong>Methods: </strong>This cross-sectional study, uniquely designed and executed, involved 318 T1DM patients sampled via census. Levels of IgA anti-tissue transglutaminase (TTG) antibodies and serum IgA were measured, with individuals having TTG-IgA levels over 10 U/mL undergoing endoscopy and duodenal biopsy. The data were meticulously analyzed using SPSS V.22, with significance at a p-value < 0.05.</p><p><strong>Results: </strong>Among the 318 patients, 25 (7.86%), comprising 15 (60%) females and 10(40%) males, underwent endoscopy and biopsy due to elevated TTG-IgA levels. Histopathological analysis revealed four (16%) patients with normal findings: 2 (8%) with Marsh type 1, 1 (4%) with Marsh type 2, and 18 (72%) with Marsh type 3. Patients with TTG levels exceeding 100 were all classified as Marsh type 3. Gender-wise, there was no significant difference in celiac disease type distribution. (P- value= 0.58).</p><p><strong>Conclusion: </strong>This study's findings, which reveal a celiac disease prevalence in T1DM patients similar to global rates, have significant implications for clinical practice. The importance of routine celiac disease screening for these patients is underscored, as is the urgent need for extensive multi-center studies to deepen our understanding of this relationship and improve patient care.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"16 4","pages":"797-800"},"PeriodicalIF":1.0,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12694773/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145741304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Human Papillomavirus (HPV) is known to be associated with various types of skin neoplasms. Organ transplant recipients (OTR) are generally at a higher risk for developing skin neoplasms, including those related to HPV, due to their immunosuppressed state. In the current meta-analysis, we aimed to evaluate the frequency of HPV-related skin cancers and related factors among OTRs.
Methods: This meta-analysis study was conducted under the guidelines of the preferred reporting items for systematic review and meta-analysis (PRISMA). The generalized I2 statistics was perfumed for assessing heterogeneity. Odds ratio (OR) and effective size were calculated in comprehensive meta-analysis (CMA) software Version 3. In addition, meta-regression analysis was conducted to examine the temporal trends in the incidence of HPV-related skin cancer among OTRs over the study years.
Results: Out of 417 potentially eligible studies, seven were included for final analysis. The most frequently reported skin cancers in OTRs were squamous cell carcinoma (SCC) and basal cell carcinoma (BCC). The result of meta-analysis also revealed a high prevalence of 61.7% (95% CI: 35.4% - 82.5%) of HPV-related skin cancer among OTRs. The male-to-female ratio was 2.14 (95% CI 0.58-7.87), and the mean time from transplantation to the first diagnosis of skin cancer was about eight years. The frequency of HPV among tumor lesions ranged from 37.7% to 74.1%.
Conclusions: These findings collectively provide insights into the prevalence of HPV among OTRs with skin neoplasms, emphasizing the need for careful consideration of heterogeneity when interpreting the overall estimate.
{"title":"Human papillomavirus-associated skin cancers among organ transplant recipients: A systematic review and meta-analysis.","authors":"Niloofar Faraji, Simin Farokhi, Arshia Fakouri, Shahab Aali, Mahsa Motiei, Kaveh Gharaei Nejad","doi":"10.22088/cjim.16.4.641","DOIUrl":"10.22088/cjim.16.4.641","url":null,"abstract":"<p><strong>Background: </strong>Human Papillomavirus (HPV) is known to be associated with various types of skin neoplasms. Organ transplant recipients (OTR) are generally at a higher risk for developing skin neoplasms, including those related to HPV, due to their immunosuppressed state. In the current meta-analysis, we aimed to evaluate the frequency of HPV-related skin cancers and related factors among OTRs.</p><p><strong>Methods: </strong>This meta-analysis study was conducted under the guidelines of the preferred reporting items for systematic review and meta-analysis (PRISMA). The generalized <i>I</i> <sup>2</sup> statistics was perfumed for assessing heterogeneity. Odds ratio (OR) and effective size were calculated in comprehensive meta-analysis (CMA) software Version 3. In addition, meta-regression analysis was conducted to examine the temporal trends in the incidence of HPV-related skin cancer among OTRs over the study years.</p><p><strong>Results: </strong>Out of 417 potentially eligible studies, seven were included for final analysis. The most frequently reported skin cancers in OTRs were squamous cell carcinoma (SCC) and basal cell carcinoma (BCC). The result of meta-analysis also revealed a high prevalence of 61.7% (95% CI: 35.4% - 82.5%) of HPV-related skin cancer among OTRs. The male-to-female ratio was 2.14 (95% CI 0.58-7.87), and the mean time from transplantation to the first diagnosis of skin cancer was about eight years. The frequency of HPV among tumor lesions ranged from 37.7% to 74.1%.</p><p><strong>Conclusions: </strong>These findings collectively provide insights into the prevalence of HPV among OTRs with skin neoplasms, emphasizing the need for careful consideration of heterogeneity when interpreting the overall estimate.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"16 4","pages":"641-650"},"PeriodicalIF":1.0,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12694852/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145740778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-15eCollection Date: 2025-01-01DOI: 10.22088/cjim.16.4.630
Mostafa Ahmadi, Seyyed Ali Mozaffarpur, Hoda Shirafkan
Background: Musculoskeletal pain is a common and bothersome condition influencing a large segment of the population. It can significantly impact individuals' quality of life and limit daily activities. Traditionally, chamomile (Matricaria chamomilla) has been used for its pain-relieving properties. This systematic review and meta-analysis aimed to investigate the efficacy of chamomile in reducing musculoskeletal pain.
Methods: We searched English language databases including Cochrane, Scopus, PubMed, Web of Science, and Google Scholar for published studies up to July 2024. Studies examining chamomile's influence on musculoskeletal discomfort in humans were included. In-vitro, animal, and observational studies were excluded.
Results: A total of eight studies were analyzed. The findings suggest a potential analgesic effect of chamomile compared to placebo. Additionally, no significant difference was found between chamomile and other pain medication. The studies included in this review, however, exhibited significant heterogeneity.
Conclusions: Chamomile may be a promising alternative for pain management due to its potential analgesic effect and lack of significant difference compared to other pain medication; however, more research is needed.
背景:肌肉骨骼疼痛是一种常见且令人烦恼的疾病,影响了很大一部分人群。它会严重影响个人的生活质量,限制日常活动。传统上,洋甘菊(洋甘菊)因其缓解疼痛的特性而被使用。本系统综述和荟萃分析旨在研究洋甘菊减轻肌肉骨骼疼痛的功效。方法:检索Cochrane、Scopus、PubMed、Web of Science和谷歌Scholar等英文数据库,检索截止到2024年7月已发表的研究。研究人员还研究了洋甘菊对人体肌肉骨骼不适的影响。排除体外、动物和观察性研究。结果:共分析了8项研究。研究结果表明,与安慰剂相比,洋甘菊具有潜在的镇痛作用。此外,洋甘菊和其他止痛药之间没有明显差异。然而,纳入本综述的研究显示出显著的异质性。结论:洋甘菊具有潜在的镇痛作用,与其他止痛药相比无显著性差异,可能是一种有前景的疼痛治疗选择;然而,还需要更多的研究。
{"title":"Effect of chamomile on musculoskeletal pain: A systematic review and meta-analysis of randomized controlled trials.","authors":"Mostafa Ahmadi, Seyyed Ali Mozaffarpur, Hoda Shirafkan","doi":"10.22088/cjim.16.4.630","DOIUrl":"10.22088/cjim.16.4.630","url":null,"abstract":"<p><strong>Background: </strong>Musculoskeletal pain is a common and bothersome condition influencing a large segment of the population. It can significantly impact individuals' quality of life and limit daily activities. Traditionally, chamomile (Matricaria chamomilla) has been used for its pain-relieving properties. This systematic review and meta-analysis aimed to investigate the efficacy of chamomile in reducing musculoskeletal pain.</p><p><strong>Methods: </strong>We searched English language databases including Cochrane, Scopus, PubMed, Web of Science, and Google Scholar for published studies up to July 2024. Studies examining chamomile's influence on musculoskeletal discomfort in humans were included. In-vitro, animal, and observational studies were excluded.</p><p><strong>Results: </strong>A total of eight studies were analyzed. The findings suggest a potential analgesic effect of chamomile compared to placebo. Additionally, no significant difference was found between chamomile and other pain medication. The studies included in this review, however, exhibited significant heterogeneity.</p><p><strong>Conclusions: </strong>Chamomile may be a promising alternative for pain management due to its potential analgesic effect and lack of significant difference compared to other pain medication; however, more research is needed.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"16 4","pages":"630-640"},"PeriodicalIF":1.0,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12695481/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145755390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}